Notes on potential side effects Step 3
Limitations and cautions with MOTS-c include: Human research is limited: Much of the available evidence comes from preclinical, mechanistic, and early-stage research
for example, mutated SOX2, amplified FGFR, and mutated DDR2 are currently being investigated in clinical trials [155]
GHK-Cus cumulative effects are visible at this stage
This is a 503A compounding discussion
In addition to its effects on insulin, GIP plays a crucial role in fat accumulation by promoting the activity of adipocyte-expressed lipoprotein lipase and promoting bone formation by preventing osteoclast apoptosis, as evidenced by the thinner bone trabeculae seen in mice lacking GIP receptors [20,21,22]